Cernais

At Cernais, we’re exploring new ways to discover medicines using our own AI-driven approach. We’re working to fine-tune how certain X-linked genes are expressed, with the goal of restoring cell function and easing the symptoms of Rett Syndrome, CDKL5 Deficiency Disorder, and similar conditions. We also provide tailored, unbiased screening services for both new and repurposed drugs — including RNA-modifying molecules.